HK1096089A1 - Succinate and malonate salt of trans-4-(ir,3s)-6-chloro-3-phenylindan-1- yl)-1,2,2-trimethylpiperazine and the use as a medicament - Google Patents

Succinate and malonate salt of trans-4-(ir,3s)-6-chloro-3-phenylindan-1- yl)-1,2,2-trimethylpiperazine and the use as a medicament

Info

Publication number
HK1096089A1
HK1096089A1 HK07103032.7A HK07103032A HK1096089A1 HK 1096089 A1 HK1096089 A1 HK 1096089A1 HK 07103032 A HK07103032 A HK 07103032A HK 1096089 A1 HK1096089 A1 HK 1096089A1
Authority
HK
Hong Kong
Prior art keywords
phenylindan
trimethylpiperazine
succinate
trans
medicament
Prior art date
Application number
HK07103032.7A
Inventor
De Diego Heidi Lopez
Ole Nielsen
Lone Munch Ringgard
Henrik Svane
Allan Carsten Dahl
Mark Howells
Benny Bang-Andersen
Lars Ole Lyngsoe
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/DK2004/000545 external-priority patent/WO2005016900A1/en
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of HK1096089A1 publication Critical patent/HK1096089A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C25/00—Compounds containing at least one halogen atom bound to a six-membered aromatic ring
    • C07C25/18—Polycyclic aromatic halogenated hydrocarbons
    • C07C25/22—Polycyclic aromatic halogenated hydrocarbons with condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/143—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
    • C07C35/32—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system being a (4.3.0) system, e.g. indenols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK07103032.7A 2003-08-18 2007-03-21 Succinate and malonate salt of trans-4-(ir,3s)-6-chloro-3-phenylindan-1- yl)-1,2,2-trimethylpiperazine and the use as a medicament HK1096089A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200301180 2003-08-18
DKPA200301305 2003-09-11
PCT/DK2004/000545 WO2005016900A1 (en) 2003-08-18 2004-08-18 Succinate and malonate salt of trans-4-(ir,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament

Publications (1)

Publication Number Publication Date
HK1096089A1 true HK1096089A1 (en) 2007-05-25

Family

ID=58707237

Family Applications (2)

Application Number Title Priority Date Filing Date
HK07103032.7A HK1096089A1 (en) 2003-08-18 2007-03-21 Succinate and malonate salt of trans-4-(ir,3s)-6-chloro-3-phenylindan-1- yl)-1,2,2-trimethylpiperazine and the use as a medicament
HK11106689.0A HK1152699A1 (en) 2003-08-18 2011-06-29 Method for preparing trans-4-((1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2- trimethylpiperazine and the salts thereof and the intermediates used therein

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK11106689.0A HK1152699A1 (en) 2003-08-18 2011-06-29 Method for preparing trans-4-((1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2- trimethylpiperazine and the salts thereof and the intermediates used therein

Country Status (16)

Country Link
KR (2) KR101227789B1 (en)
CN (1) CN101935305B (en)
AR (2) AR045278A1 (en)
AT (1) ATE552247T1 (en)
DK (1) DK1658277T3 (en)
EA (2) EA014641B1 (en)
ES (1) ES2383369T3 (en)
HK (2) HK1096089A1 (en)
IS (1) IS8264A (en)
ME (1) MEP2408A (en)
MY (2) MY154535A (en)
PT (1) PT1658277E (en)
RS (3) RS20060083A (en)
SG (2) SG148183A1 (en)
SI (1) SI1658277T1 (en)
TW (2) TWI403505B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI453198B (en) * 2005-02-16 2014-09-21 Lundbeck & Co As H Process for making the trans-1-( (1r , 3s)- 6-chloro - 3 -phenylindan-1- yl ) - 3 , 3 - dimethylpiperazine and salts thereof and for making 4 -((1r , 3s )-6- chloro- 3- phenylindan -1- yl )-1, 2 , 2 -trimethylpiperazine and salts thereof
PL2720989T3 (en) 2011-06-20 2017-05-31 H. Lundbeck A/S Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE50867B1 (en) * 1980-02-29 1986-08-06 Kefalas As Indane derivatives
DK55192D0 (en) * 1992-04-28 1992-04-28 Lundbeck & Co As H 1-piperazino-1,2-dihydroindene derivatives

Also Published As

Publication number Publication date
EA014641B1 (en) 2010-12-30
ATE552247T1 (en) 2012-04-15
MY154535A (en) 2015-06-30
AR045278A1 (en) 2005-10-19
KR101227789B1 (en) 2013-01-30
IS8264A (en) 2006-01-26
SI1658277T1 (en) 2012-10-30
CN101935305A (en) 2011-01-05
KR20060066094A (en) 2006-06-15
RS20060121A (en) 2008-09-29
ES2383369T3 (en) 2012-06-20
AR045279A1 (en) 2005-10-19
RS20060083A (en) 2008-08-07
MY149089A (en) 2013-07-15
TWI403505B (en) 2013-08-01
SG148183A1 (en) 2008-12-31
TW201111351A (en) 2011-04-01
HK1152699A1 (en) 2012-03-09
EA200600443A1 (en) 2006-08-25
TW200519098A (en) 2005-06-16
DK1658277T3 (en) 2012-06-18
KR20060066104A (en) 2006-06-15
PT1658277E (en) 2012-05-25
MEP2408A (en) 2010-02-10
RS53369B (en) 2014-10-31
CN101935305B (en) 2013-04-10
SG145723A1 (en) 2008-09-29
EA200600441A1 (en) 2006-08-25
TWI388550B (en) 2013-03-11

Similar Documents

Publication Publication Date Title
PL1658277T3 (en) Succinate and malonate salt of trans-4-(ir,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament
EG25011A (en) Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments.
AU2003212282A1 (en) Cdk inhibiting 2-heteroaryl pyrimidine, the production thereof, and use thereof as a medicament
HK1084123A1 (en) Novel fluoroglycoside heterocyclic derivatives, pharmaceutical products containing said compounds and the use thereof
AU2003241327A1 (en) Amidinylphenyl compounds and their use as fungicides
HK1080482A1 (en) Novel thiophenylglycoside derivatives, methods forproduction thereof, medicaments comprising said c ompounds and use thereof
HK1084124A1 (en) Novel aromatic fluoroglycoside derivatives, pharmaceutical products containing said compounds and the use thereof
ZA200407986B (en) Substituted phenylacetamides and their use as glucokinase activators.
AU2003289641A1 (en) The novel coumarin-amide derivatives and its preparation, said drug composition and its use
AU2003216934A1 (en) Benzoxazinone derivatives, the preparation and use thereof as medicaments
AU2003279442A1 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
AU2002361326A1 (en) 4-(oxadiazol-3-yl)-1,4-diazabicyclo(3.2.2)-nonane derivatives, preparation and therapeutic use thereof
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
AU2003224747A1 (en) Technetium-labeled rotenone derivatives, and methods of use thereof
HK1096089A1 (en) Succinate and malonate salt of trans-4-(ir,3s)-6-chloro-3-phenylindan-1- yl)-1,2,2-trimethylpiperazine and the use as a medicament
PT1532141E (en) 2-pyrrolidin-2-yl- [1,3,4]-oxadiazole derivatives and the use of the same as antidepressants
AU2003232785A1 (en) Novel anthracene derivatives and the use thereof as a medicament
HRP20040691A2 (en) 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine and the use thereof as a drug
AU2002335304A1 (en) The use of berberine as insulin sensitizer
AU2003294952A1 (en) 3,3-dimethyl-8-oxoisoquinolines for medical purposes, methods for the production thereof, medicaments containing said compounds and the use of the same
AU2003239445A1 (en) Medical clothing
AU2003232698A1 (en) Use of a n,n'-dibenzyl-thiourea as medicine
AU2003206975A1 (en) Self-destructing syringe
AU2003255063A1 (en) The medical use of 11,11`-dideoxyverticillin a
SI1500654T1 (en) Benzoxazinone derivatives, the preparation and use thereof as medicaments

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210818